LAXMI DENTAL LIMITED is a Healthcare Equipment & Supplies company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY25 | FY26 |
|---|---|---|
| Revenue | 239 | 278 |
| EBITDA (ex other income) | 49 | 38 |
| margin % | 20.5 | 13.5 |
| Owners' profit | 32 | 29 |
| EPS, as reported (₹) | 6.06 | 5.53 |
| ROE % · ROCE % | 15.3 · 16.3 | 11.8 · 11.5 |
| Debt / equity (x) | 0.05 | 0.00 |
| Cash from operations | 44 | (5) |
| Capex | (15) | (16) |
| ₹ crore | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 62 | 61 | 66 | 72 | 66 | 74 | 75 |
| Profit before tax | 5 | 6 | 10 | 9 | (1) | 11 | 12 |
| Net profit | 5 | 4 | 8 | 9 | 2 | 10 | 10 |
| EPS (₹) | 0.88 | 0.79 | 1.53 | 1.59 | 0.37 | 1.83 | 1.87 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Laboratory Business | 102 | 36.3 |
| Aligners Business | 38 | 13.3 |
| Other business | 4 | 1.5 |
| Other Business | 2 | 0.7 |
| Laboratory business | 50 | 17.7 |
| Aligners business | 20 | 7.2 |
| LABORATORY BUSINESS | 45 | 15.8 |
| ALIGNERS BUSINESS | 19 | 6.6 |
| OTHER BUSINESS | 3 | 0.9 |
| Total, before eliminations | 282 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B |
|---|
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 4 Sept 2026 · Laxmi Dental to host analyst/investor meet on Sept 9 | investor communications | low | — | — |
| 4 Sept 2026 · Annual Report FY26 and 22nd AGM notice dispatched | compliance | minimal | — | — |
| 3 Sept 2026 · Laxmi Dental 22nd AGM notice and FY26 Annual Report filed with exchanges | board shareholder meetings | low | — | — |
| 3 Sept 2026 · 22nd AGM on Sep 25, 2026; proposes IPO proceeds reallocation | board shareholder meetings | low | — | — |
| 3 Sept 2026 · Laxmi Dental to reallocate INR 481M unutilized IPO funds for new facility | compliance | minimal | — | — |
| 2 Sept 2026 · Newspaper publication of 22nd AGM notice | compliance | minimal | — | — |
| 31 Aug 2026 · ESOP shares get NSE BSE listing approval | capital market events | low | — | — |
| 27 Aug 2026 · Laxmi Dental: ESOP allotment, IPO fund reallocation and trading window closure | compliance | minimal | — | — |
| 27 Aug 2026 · ESOP allotment and proposed reallocation of IPO proceeds | capital market events | low | — | — |
| 27 Aug 2026 · Board approves ESOP allotment and IPO fund reallocation | board shareholder meetings | medium | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| EV/EBITDA |
|---|
| ROE % |
|---|
| ROCE % |
|---|
| Rev CAGR 5y % |
|---|
| EBITDA m. % |
|---|
| POLY MEDICURE LIMITED | 17,626 | 55.9 | 5.60 | 32.3 | 10.2 | 12.6 | 19.0 | 30.2 |
| FISCHER MEDICAL VENTURE L | 2,353 | 15.0 | 6.11 | 43.6 | 8.1 | 11.3 | — | 15.5 |
| TARSONS PRODUCTS LIMITED | 1,657 | 149.0 | 2.61 | 14.3 | 2.3 | 2.4 | — | 29.0 |
| LAXMI DENTAL LIMITED ◆ | 1,121 | 36.0 | 4.59 | 24.1 | 11.8 | 11.0 | — | 22.3 |
| FABTECH TECHNOLOGIES LTD | 650 | 10.6 | 1.55 | 10.6 | 9.1 | 10.7 | — | 9.9 |
| Hemant Surgical Industries Lim | 613 | 23.4 | — | — | — | 16.7 | — | — |
| Prevest Denpro Limited | 489 | 16.5 | — | — | — | 21.9 | — | — |
| NURECA LIMITED | 318 | 65.2 | 1.76 | 38.3 | 1.2 | 2.7 | (7.2) | 13.0 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 36.0 | 20.0 | 12 of 17 | 31% |
| P/B | 4.6 | 2.7 | 9 of 11 | 20% |
| ROCE | 11.0 | 11.3 | 11 of 17 | 38% |
| ROE | 11.8 | 8.1 | 3 of 11 | 80% |
| Debt / Equity | 0.0 | 0.1 | 1 of 11 | 90% |
| EBITDA margin | 22.3 | 16.7 | 4 of 11 | 70% |
| Revenue growth | 13.9 | 13.9 | 8 of 13 | 42% |
| Profit growth | 23.8 | 75.5 | 6 of 10 | 44% |
| Market cap | 1121 | 175 | 4 of 17 | 81% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
